ENVISIA THERAPEUTICS
As many as 285 million people suffer from disease-related visual impairments and blindness1, but an estimated 80 percent of these visual impairments are actually preventable2. Unfortunately, the safety and effectiveness of many medical therapies for ocular disorders are limited due to poor drug uptake, non-specificity to target tissues, systemic side effects, or poor adherence to therapy. With a rapidly aging population, the unmet medical needs in ocular disease are becoming even more pronounced. As a result, patients and physicians are seeking improved ocular therapeutics that can significantly enhance patient outcomes and convenience.
ENVISIA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2013-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.envisiatherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
(919)973-1440
Email Addresses:
[email protected]
Total Funding:
46.1 M USD
Technology used in webpage:
SPF Amazon New Relic Amazon Ohio Region NameBright
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Series A - Envisia Therapeutics
Morningside Group
Morningside Group investment in Series A - Envisia Therapeutics
Pappas Ventures
Pappas Ventures investment in Series A - Envisia Therapeutics
Wakefield Group
Wakefield Group investment in Series A - Envisia Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series A - Envisia Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-09-10 | LQ3 Pharmaceuticals | Envisia Therapeutics investment in Series A - LQ3 Pharmaceuticals | 10 M USD |
Official Site Inspections
http://www.envisiatherapeutics.com
- Host name: ec2-54-161-222-85.compute-1.amazonaws.com
- IP address: 54.161.222.85
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
